Phallacidin
Cat.No:IP4010 Solarbio
CAS:26645-35-2
Molecular Formula:C37H50N8O13S
Molecular Weight:846.9
Storage:Powder:-20℃,1 year;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥90%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Cytoskeleton >
PhallacidinCAS:26645-35-2
Molecular Formula:C37H50N8O13S
Molecular Weight:846.9
Storage:Powder:-20℃,1 year;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥90%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 26645-35-2 |
Name | Phallacidin |
Molecular Formula | C37H50N8O13S |
Molecular Weight | 846.9 |
Solubility | Soluble in Water(Need ultrasonic) |
Purity | ≥90% |
Appearance | White to off-white Solid |
Storage | Powder:-20℃,1 year;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00063359 |
SMILES | CC1C(=O)NC2CC3=C(NC4=CC=CC=C34)SCC(C(=O)N5CC(CC5C(=O)N1)O)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC(C)(CO)O)C(C)C)C(C(=O)O)O |
InChIKey | KUBDTFZQCYLLGC-UHFFFAOYSA-N |
InChI | InChI=1S/C37H50N8O13S/c1-15(2)25-32(53)44-26(27(48)36(56)57)33(54)41-23-13-59-34-19(18-7-5-6-8-20(18)42-34)10-21(29(50)40-22(30(51)43-25)11-37(4,58)14-46)39-28(49)16(3)38-31(52)24-9-17(47)12-45(24)35(23)55/h5-8,15-17,21-27,42,46-48,58H,9-14H2,1-4H3,(H,38,52)(H,39,49)(H,40,50)(H,41,54)(H,43,51)(H,44,53)(H,56,57) |
PubChem CID | 3034055 |
Target Point | F-actin |
Passage | Cytoskeleton |
Background | Phallacidin binds to F-actin. |
Unit | Bottle |
Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.